Vorasidenib Expanded Access Program

Clinical trial NCT05592743 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT05592743
Sponsor: Servier
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Glioma Recurrence Disease Attributes Pathologic Processes Neoplasms, Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Diffuse Glioma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.